Polyzos, Aristides <br/><br/>
FEC versus sequential docetaxel followed by epirubicin/cyclophosphamide as adjuvant chemotherapy in women with axillary node-positive early breast cancer: a randomized study of the Hellenic Oncology Research Group (HORG).  [electronic resource] 

 -  Breast cancer research and treatment  Jan 2010 
 - 95-104 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1573-7217 
<br/><br/><label>Standard No.: </label>10.1007/s10549-009-0468-0  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--drug therapy<br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Breast Neoplasms--drug therapy<br/>Chemotherapy, Adjuvant--methods<br/>Cyclophosphamide--administration & dosage<br/>Disease-Free Survival<br/>Epirubicin--administration & dosage<br/>Female<br/>Fluorouracil--therapeutic use<br/>Humans<br/>Lymphatic Metastasis<br/>Middle Aged<br/>Time Factors<br/>Treatment Outcome